Blog - Page 2 of 5693 - QualityStocks

WednesdayJul 22, 2026 9:10 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Appoints Chief Revenue Officer to Lead Commercial Strategy

American Fusion (OTC: AMFN) has appointed Alec Rossa as chief revenue officer, tasking the longtime executive with leading the company's global commercial strategy as it advances development of its proprietary Texatron(TM) Fusion Engine(TM). Rossa will oversee customer development, strategic partnerships, government and institutional relationships and commercialization of the company's planned Power-as-a-Service ("PaaS") business model. He previously spent nearly two decades as president and CEO of MD Charlton Ltd., where he expanded the business into Canada's largest national distributor of police and tactical equipment while building relationships across government, defense and public safety organizations. The company said Rossa's experience negotiating complex…

WednesdayJul 22, 2026 9:00 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Reports High-Grade Oxide Gold Intercept at Santa Fe

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced additional results from its 2026 drilling program at the Santa Fe Mine project in Nevada, highlighted by a geotechnical diamond drill hole at the Calvada deposit that also intersected significant oxide gold mineralization. Hole CAL26-03C returned 30.8 meters grading 0.93 grams per tonne gold equivalent ("Au Eq"), including a higher-grade interval of 10.7 meters grading 2.18 g/t Au Eq. The company said the intercept ranks among the highest-grade results drilled to date within the Central Calvada deposit…

WednesdayJul 22, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany

The company has received Scientific Advice from Germany's Paul-Ehrlich-Institute (“PEI”) supporting the proposed development strategy for its lead BiTAC(R)-TCE program. The regulatory feedback provides early guidance on the company's biological rationale, safety assessments, and non-clinical development plan, for its novel therapeutic platform. VERAXA believes the advice helps reduce development uncertainty by providing greater clarity before advancing toward clinical studies. The company's lead BiTAC(R)-TCE candidate previously generated encouraging preclinical data presented at the 2026 American Association for Cancer Research (“AACR”) Annual Meeting. VERAXA continues to build a diversified oncology pipeline that includes bispecific T-cell engagers, antibody-drug conjugates (“ADCs”) and other engineered…

TuesdayJul 21, 2026 3:22 pm

QualityStocksNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Hits Key Milestone, Builds Momentum with AI-Powered Platform

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was recently added as a member of the Russell Microcap Index. An article discussing this highlights the notable milestone for Beeline as it joins a group of small-cap companies tracked by institutional investors and index-linked funds. “Chief Executive Officer Nick Liuzza said the company expects the addition to improve trading liquidity and broaden investor exposure to the business,” reads the article. “Beeline has spent the last several years positioning itself as a technology-focused alternative to traditional mortgage originators. Through its subsidiary, Beeline…

TuesdayJul 21, 2026 3:00 pm

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Eyes First Gold Poor as Production Restart Nears

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) is advancing toward near-term gold production as it prepares to restart operations at its Beacon Gold Mill in Québec’s Abitibi Gold Belt, using a 100,000-metric-ton bulk sample from its Swanson Gold Project as a feed source for its first gold pour. With gold prices remaining well above historical levels, the company expects to benefit from strong margins, supported by a preliminary economic assessment that anticipates a solid return from the operation. Recent high-grade drill results at Swanson, ongoing mill upgrades, and…

TuesdayJul 21, 2026 1:27 pm

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Deploys Cutting-Edge Exploration Technology at Ontario Project

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) recently engaged Stanford University-originated exploration technology company ExploreTech to conduct an independent data review and drill optimization at its Schryburt Lake REE-Niobium Project in Ontario. Using its proprietary engine, which applies probabilistic modeling to identify high-priority exploration targets, ExploreTech will refine the geometry and depth of four key target areas—Goldfinch, Blue Jay, Blackbird and Starling—while optimizing drill collar placement and delivering a phased drilling sequence for Canamera’s planned 1,500-meter, nine-hole helicopter-supported diamond drilling program. The collaboration is intended to…

TuesdayJul 21, 2026 1:07 pm

QualityStocksNewsBreaks – VivoSim Labs, Inc. (NASDAQ: VIVS) Announces $4 Million Private Placement

VivoSim Labs, Inc. (NASDAQ: VIVS) announced it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to raise approximately $4 million in gross proceeds through a private placement of 4,705,883 shares of common stock, or common stock equivalents, and accompanying warrants priced at a combined $0.85 per share. The warrants, which are exercisable following shareholder approval and expire five years after their initial exercise date, carry an exercise price of $0.85 per share. The company also agreed, subject to shareholder approval, to amend certain existing May 2024 warrants by reducing their exercise price from $9.60 to $0.85 per share. The offering is…

TuesdayJul 21, 2026 12:40 pm

QualityStocksNewsBreaks – Greenwich LifeSciences, Inc. (NASDAQ: GLSI) Highlights Phase 3 Trial Progress and Expanded Study Design

Greenwich LifeSciences (NASDAQ: GLSI) provided an update on its Phase 3 FLAMINGO-01 trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrence, announcing that the study's Data Safety Monitoring Board recommended the trial continue without modification following its May 2026 review. The company also said regulatory authorities in the U.S. and Europe have supported planned protocol changes that include expanding enrollment to as many as 2,000 patients, increasing enrollment rates by including all HLA types and maintaining enrollment through interim analyses to strengthen the study design and increase the probability of success. Greenwich LifeSciences said more than 1,500 patients…

TuesdayJul 21, 2026 11:15 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma's MS focus is Lucid-MS, a patented new chemical entity that takes a fundamentally different approach from existing therapies. Supporting Lucid-MS’s phase 2 development is an ongoing imaging collaboration with Massachusetts General Hospital. The company developed unbuzzd, a proprietary dietary supplement formulated to support alcohol metabolism and reduce the acute effects of intoxication and hangover. Neurological disorders affect hundreds of millions of people worldwide, and for many of those patients, existing treatments fall far short. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company, is…

TuesdayJul 21, 2026 10:30 am

American Fusion(TM) Inc. (AMFN) Secures Texas Certificate of Registration as Texatron(TM) Fusion Engine(TM) Testing Program Advances

The company has received a Texas DSHS Certificate of Registration for Industrial Radiation Machines, allowing research and development activities involving its registered Texatron(TM) Fusion Engine(TM) systems at Texas Tech University. The registration provides the principal regulatory authorization supporting the company's planned engineering, prototype testing, and validation roadmap, under applicable Texas radiation control regulations. The certificate covers 12 Texatron(TM) Fusion Engine(TM) research systems, ranging from 500 kW to 1 GW, reflecting the breadth of the company's planned development platform. The milestone follows months of regulatory review and supports the next phase of the company's technical development program, including calibration, diagnostics and…

Site Search

Company Search